BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lanthier N. Les nouveaux traitements de la stéatohépatite non-alcoolique. Nutrition Clinique et Métabolisme 2020;34:216-22. [DOI: 10.1016/j.nupar.2020.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Goffaux A, Delorme A, Dahlqvist G, Lanthier N. Improving the prognosis before and after liver transplantation: Is muscle a game changer? World J Gastroenterol 2022; 28(40): 5807-5817 [DOI: 10.3748/wjg.v28.i40.5807] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lanthier N, Delzenne N. Targeting the Gut Microbiome to Treat Metabolic Dysfunction-Associated Fatty Liver Disease: Ready for Prime Time? Cells 2022;11:2718. [DOI: 10.3390/cells11172718] [Reference Citation Analysis]
3 André-dumont SI, Lanthier N. Quelle alimentation proposer aux patients présentant une stéatohépatite non-alcoolique ? Nutrition Clinique et Métabolisme 2022;36:12-20. [DOI: 10.1016/j.nupar.2021.11.001] [Reference Citation Analysis]
4 Clarembeau F, Bale G, Lanthier N. Cirrhosis and insulin resistance: current knowledge, pathophysiological mechanisms, complications and potential treatments. Clin Sci (Lond) 2020;134:2117-35. [PMID: 32820802 DOI: 10.1042/CS20200022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]